CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 35 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,000 | -11.1% | 14,575 | -2.0% | 0.00% | – |
| Q2 2017 | $9,000 | -70.0% | 14,870 | -11.7% | 0.00% | -100.0% |
| Q1 2017 | $30,000 | +30.4% | 16,840 | -10.2% | 0.00% | – |
| Q4 2016 | $23,000 | +9.5% | 18,751 | -3.1% | 0.00% | – |
| Q3 2016 | $21,000 | -4.5% | 19,342 | -9.9% | 0.00% | – |
| Q2 2016 | $22,000 | -21.4% | 21,460 | -8.5% | 0.00% | -100.0% |
| Q1 2016 | $28,000 | -33.3% | 23,457 | -13.8% | 0.00% | 0.0% |
| Q4 2015 | $42,000 | -33.3% | 27,219 | -9.7% | 0.00% | -50.0% |
| Q3 2015 | $63,000 | – | 30,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|